Literature DB >> 1472100

Inhibition of proliferation of human leukaemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro.

T W Lo1, P J Thornalley.   

Abstract

Diethyl esters of the glutathione S-conjugate S-p-bromobenzylglutathione, an inhibitor of glyoxalase I, and S-p-nitrobenzoxycarbonylglutathione, an inhibitor of glyoxalase II, induced growth arrest and toxicity in human leukaemia 60 cells in culture. The median growth inhibitory concentration IC50 values were 8.3 microM (95% C.I. 7.0-9.9 microM) for S-p-bromobenzylglutathione diethyl ester and 56 microM (95% C.I. 36-86 microM) for p-nitrobenzoxycarbonylglutathione. Monoethyl ester and unesterified derivatives were inactive. The diethyl ester derivatives were also toxic to mature human neutrophils under the same culture conditions where the respective median toxic concentration IC50 values were 39.7 (95% C.I. 35.4-44.5 microM) and 127 (95% C.I. 123-132 microM) microM. Diester derivatives may be of future interest in studying the cytotoxicity of glutathione S-conjugates and for the development of cytotoxic anti-tumour agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472100     DOI: 10.1016/0006-2952(92)90680-h

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line.

Authors:  S Ranganathan; E S Walsh; K D Tew
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

Review 3.  Glo1 inhibitors for neuropsychiatric and anti-epileptic drug development.

Authors:  Katherine M J McMurray; Margaret G Distler; Preetpal S Sidhu; James M Cook; Leggy A Arnold; Abraham A Palmer; Leigh D Plant
Journal:  Biochem Soc Trans       Date:  2014-04       Impact factor: 5.407

Review 4.  Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.

Authors:  Paul J Thornalley
Journal:  Drug Metabol Drug Interact       Date:  2008

Review 5.  Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.

Authors:  Naila Rabbani; Mingzhan Xue; Paul J Thornalley
Journal:  Glycoconj J       Date:  2016-07-12       Impact factor: 2.916

6.  Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death.

Authors:  Marie-Julie Nokin; Florence Durieux; Justine Bellier; Olivier Peulen; Koji Uchida; David A Spiegel; James R Cochrane; Craig A Hutton; Vincent Castronovo; Akeila Bellahcène
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

7.  Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.

Authors:  Nele Kreycy; Christiane Gotzian; Thomas Fleming; Christa Flechtenmacher; Niels Grabe; Peter Plinkert; Jochen Hess; Karim Zaoui
Journal:  BMC Cancer       Date:  2017-05-26       Impact factor: 4.430

8.  Methylglyoxal evokes pain by stimulating TRPA1.

Authors:  David A Andersson; Clive Gentry; Emily Light; Nisha Vastani; Julie Vallortigara; Angelika Bierhaus; Thomas Fleming; Stuart Bevan
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

9.  Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum.

Authors:  Cletus A Wezena; Miriam Urscher; Robert Vince; Swati S More; Marcel Deponte
Journal:  Redox Biol       Date:  2016-03-02       Impact factor: 11.799

Review 10.  The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).

Authors:  Marcus Hollenbach
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.